new CCFA Community: Join the Discussion!
Sign up for CCFA's Free
E-mail Newsletter:
About CCFA
Our Mission
2010 Strategic Plan
Your Dollars at Work
Annual Report
Our Members & Partners
Press Room
Our Pharmaceutical Sponsors
Employment
Living with IBD
Information Resource Center
CCFA Community
Disease Information
How You Can Help
Research
Chapters & Events
Kids & Teens
Advocacy
Science & Professionals
Shop CCFA
E-mail
Password
Remember
my Login

Enter Keyword(s):
Google Custom Search

donate

join

find clinical trials

find physicians

corporate partners

contact us

press

site map

About the Crohn's & Colitis Foundation of America

Profile

The mission of the Crohn's & Colitis Foundation of America, Inc. (CCFA) is to cure and prevent Crohn's disease and ulcerative colitis through research, and to improve the quality of life of children and adults affected by these digestive diseases through education and support. Known collectively as inflammatory bowel diseases (IBD), these painful, chronic illnesses affect approximately 1.4 million Americans, including some 140,000 children under the age of 18. CCFA was founded in 1967.

The Diseases

  • Crohn's disease is a painful, incurable illness that may inflame the small and large intestines and cause diarrhea, abdominal cramps, weight loss, and numerous complications, such as bowel obstruction and abscesses.
  • Ulcerative colitis attacks the large intestine (colon), causing painful diarrhea, bleeding, and numerous complications, including colon cancer. While medications control most symptoms, the only cure is surgical removal of the colon.
  • Most of those affected are young, including teenagers and young children. Approximately 20 percent of patients have another family member affected by the disease, and families frequently share a similar pattern of disease.

Funding

CCFA is supported solely by individual, foundation, and corporate contributions.

  • More than 80 cents of every dollar CCFA spends goes directly into research and educational programs.
  • CCFA is among the top-rated charities in the the American Institute of Philanthropy's Charity Rating Guide (www.charitywatch.org).

Research

Since CCFA's inception, approximately $106 million has been provided for researchers attempting to find the causes of, and cures for, IBD. Each year, more than 80 current and ongoing research grants are funded. More than 60 percent of CCFA-sponsored researchers have obtained subsequent funding from the National Institutes of Health for further IBD research.

In 2001, NOD2, the first gene linked to Crohn's disease, was discovered. This breakthrough was funded in part by a CCFA research grant. CCFA continues to accelerate the pace of IBD research by collaborating with top researchers and clinicians. CCFA-sponsored research, such as "Challenges in IBD Research," a series of top-priority initiatives, the DNA and Cell Line Bank, and the Clinical Alliance, is forging new collaborations and providing vital resources for investigators nationwide.

Education and Supportive Services

CCFA provides educational programs for patients, physicians, and the public, including Webcasts and live education seminars; 300 active support groups; chapter newsletters; a national magazine; informational brochures and books; a Web site (www.ccfa.org); a scientific journal; professional medical forums; and research publications. The foundation distributes more than one million pieces of literature every year.

Affiliations

CCFA is a member of the National Health Coalition and a founding member of the Digestive Disease National Coalition.

National Headquarters

Crohn's & Colitis Foundation of America
386 Park Avenue South
New York, NY 10016-8804
(800) 932-2423
Fax: (212) 779-4098
E-mail: info@ccfa.org
Web site: www.ccfa.org

Toll-Free Information Hotline

For requests for free brochures about IBD & information about CCFA: (800) 343-3637.